{"transactions":[{"id":747903,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:26:21.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":16999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":16999,"derivative":{"exercise_price":16.15,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Ordinary Shares","underlying_shares":16999},"source":{"system":"sec-edgar","filing":"0001310880-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000131088026000006/primarydocument.xml","form_type":"4"}},{"id":747902,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-05T20:26:21.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":11610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders."}],"balance_after":32075,"source":{"system":"sec-edgar","filing":"0001310880-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000131088026000006/primarydocument.xml","form_type":"4"}},{"id":751695,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-03T20:52:31.000Z","date":"2026-06-02","kind":"sale","planned":false,"acquired":false,"shares":2945,"price":15.7707,"value":46444.7115,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $15.65 USD to $15.88 USD; the price reported above reflects the weighted average sale price."}],"balance_after":20465,"source":{"system":"sec-edgar","filing":"0001310880-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000131088026000005/primarydocument.xml","form_type":"4"}},{"id":867961,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T00:50:55.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":1995012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":1995012,"derivative":{"exercise_price":5.91,"expiration_date":"2036-02-26","underlying":"Class A Common Stock","underlying_shares":1995012},"source":{"system":"sec-edgar","filing":"0001310880-26-000003","document":"form4-03042026_120352.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000131088026000003/form4-03042026_120352.xml","form_type":"4"}},{"id":1106403,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Class A Common Stock","published_at":"2025-06-18T20:05:05.000Z","date":"2025-06-16","kind":"purchase","planned":false,"acquired":true,"shares":500000,"price":1.787,"value":893500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":") The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.64 to $1.88, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":59281054,"source":{"system":"sec-edgar","filing":"0001415889-25-017656","document":"form4-06182025_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925017656/form4-06182025_040601.xml","form_type":"4"}},{"id":1119606,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:14:44.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":16697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders."}],"balance_after":16697,"derivative":{"exercise_price":16.72,"exercise_date":"2026-06-04","expiration_date":"2035-06-04","underlying":"Ordinary Shares","underlying_shares":16697},"source":{"system":"sec-edgar","filing":"0001562180-25-004556","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025004556/primarydocument.xml","form_type":"4"}},{"id":1119605,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-06T20:14:44.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":11215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders."}],"balance_after":23410,"source":{"system":"sec-edgar","filing":"0001562180-25-004556","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025004556/primarydocument.xml","form_type":"4"}},{"id":1122876,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-06-04T20:11:57.000Z","date":"2025-06-03","kind":"sale","planned":false,"acquired":false,"shares":999,"price":17.2968,"value":17279.5032,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $17.1025 USD to $17.50 USD; the price reported above reflects the weighted average sale price."}],"balance_after":12195,"source":{"system":"sec-edgar","filing":"0001562180-25-004428","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218025004428/primarydocument.xml","form_type":"4"}},{"id":1175695,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Class A Common Stock","published_at":"2025-04-09T01:30:51.000Z","date":"2025-04-07","kind":"purchase","planned":false,"acquired":true,"shares":300000,"price":1.625,"value":487500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":") The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.54 to $1.78, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":58781054,"source":{"system":"sec-edgar","filing":"0001415889-25-010446","document":"form4-04092025_010447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925010446/form4-04092025_010447.xml","form_type":"4"}},{"id":1175694,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Class A Common Stock","published_at":"2025-04-09T01:30:51.000Z","date":"2025-04-04","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":1.6636,"value":332720.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.6499 to $1.6699, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":58481054,"source":{"system":"sec-edgar","filing":"0001415889-25-010446","document":"form4-04092025_010447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925010446/form4-04092025_010447.xml","form_type":"4"}},{"id":1229182,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-04T23:33:16.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 2/28/2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":2000000,"derivative":{"exercise_price":1.97,"expiration_date":"2035-02-27","underlying":"Class B Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001415889-25-006692","document":"form4-03042025_110312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925006692/form4-03042025_110312.xml","form_type":"4"}},{"id":1488405,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T21:55:35.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":6229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 6,229 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders."}],"balance_after":6229,"derivative":{"exercise_price":23.13,"expiration_date":"2034-06-04","underlying":"Ordinary Shares","underlying_shares":6229},"source":{"system":"sec-edgar","filing":"0001562180-24-004768","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024004768/primarydocument.xml","form_type":"4"}},{"id":1488404,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-06T21:55:35.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":4053,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders."}],"balance_after":13194,"source":{"system":"sec-edgar","filing":"0001562180-24-004768","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218024004768/primarydocument.xml","form_type":"4"}},{"id":1603433,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-04T21:20:13.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":2000000,"derivative":{"exercise_price":1.87,"expiration_date":"2034-02-27","underlying":"Class A Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001415889-24-006276","document":"form4-03042024_090313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588924006276/form4-03042024_090313.xml","form_type":"4"}},{"id":1860484,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T20:04:57.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":12554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to buy 12,554 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2024 annual general meeting of shareholders."}],"balance_after":12554,"derivative":{"exercise_price":48.66,"exercise_date":"2024-06-07","expiration_date":"2033-06-06","underlying":"Ordinary Shares","underlying_shares":12554},"source":{"system":"sec-edgar","filing":"0001562180-23-005015","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000156218023005015/primarydocument.xml","form_type":"4"}},{"id":1979871,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-02T23:01:05.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":2500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":2500000,"derivative":{"exercise_price":1.94,"expiration_date":"2033-02-27","underlying":"Class A Common Stock","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0001209191-23-014890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919123014890/doc4.xml","form_type":"4"}},{"id":1979870,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2023-03-02T23:01:05.000Z","date":"2021-03-02","kind":"other","acquired":false,"shares":368408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 2, 2021, the Reporting Person surrendered 368,408 shares of the Issuer's Class A Common Stock in connection with the satisfaction of the Issuer's obligations to GiraFpharma LLC."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,661 shares acquired on May 19, 2022 and 1 share acquired on November 18, 2022 under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":58281054,"source":{"system":"sec-edgar","filing":"0001209191-23-014890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919123014890/doc4.xml","form_type":"4"}},{"id":2235898,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Buy Ordinary Shares","published_at":"2022-06-10T20:11:50.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":4350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 4,350 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2023 annual general meeting of shareholders."}],"balance_after":4350,"derivative":{"exercise_price":77.25,"expiration_date":"2032-06-08","underlying":"Ordinary Shares","underlying_shares":4350},"source":{"system":"sec-edgar","filing":"0001645113-22-000054","document":"wf-form4_165489189409829.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000054/wf-form4_165489189409829.xml","form_type":"4"}},{"id":2235897,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-10T20:11:50.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":2427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2023 annual general meeting of shareholders."}],"balance_after":9141,"source":{"system":"sec-edgar","filing":"0001645113-22-000054","document":"wf-form4_165489189409829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511322000054/wf-form4_165489189409829.xml","form_type":"4"}},{"id":2361191,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-02T19:29:41.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests as to 25% on the one year anniversary of 2/28/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":2000000,"derivative":{"exercise_price":5.06,"expiration_date":"2032-02-27","underlying":"Class A Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001209191-22-014581","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919122014581/doc4.xml","form_type":"4"}},{"id":2671944,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Buy Ordinary Shares","published_at":"2021-06-11T20:19:53.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":1499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 1,499 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders."}],"balance_after":1499,"derivative":{"exercise_price":211.89,"expiration_date":"2031-06-09","underlying":"Ordinary Shares","underlying_shares":1499},"source":{"system":"sec-edgar","filing":"0001645113-21-000075","document":"wf-form4_162344277249172.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000075/wf-form4_162344277249172.xml","form_type":"4"}},{"id":2671943,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-11T20:19:53.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders."}],"balance_after":6714,"source":{"system":"sec-edgar","filing":"0001645113-21-000075","document":"wf-form4_162344277249172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511321000075/wf-form4_162344277249172.xml","form_type":"4"}},{"id":2794885,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-11T21:35:30.000Z","date":"2021-03-09","kind":"grant","acquired":true,"shares":224760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests upon the achievement of certain performance goals, including market-price goals, through the fifth anniversary of March 9, 2021, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":224760,"derivative":{"exercise_price":12.66,"expiration_date":"2031-03-08","underlying":"Common Stock","underlying_shares":224760},"source":{"system":"sec-edgar","filing":"0001209191-21-019786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919121019786/doc4.xml","form_type":"4"}},{"id":2794884,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-11T21:35:30.000Z","date":"2021-03-09","kind":"grant","acquired":true,"shares":165465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 3/9/2021, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":165465,"derivative":{"exercise_price":12.66,"expiration_date":"2031-03-08","underlying":"Common Stock","underlying_shares":165465},"source":{"system":"sec-edgar","filing":"0001209191-21-019786","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919121019786/doc4.xml","form_type":"4"}},{"id":2863782,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Class B Common Stock","published_at":"2021-02-12T22:45:12.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain \"Permitted Transfers\" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Received pursuant to the Agreement and Plan of Merger, dated as of October 20, 2020, by and among Panacea Acquisition Corp. (\"Panacea\") and Panacea Merger Subsidiary Corp., a direct, wholly-owned subsidiary of Panacea (\"Merger Sub\"), and Nuvation Bio Inc. (\"Legacy Nuvation\") pursuant to which, as a result of a merger between Legacy Nuvation and Merger Sub, Legacy Nuvation became a direct, wholly-owned subsidiary of Panacea, which subsequently changed its name to Nuvation Bio Inc. (the \"Issuer\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain \"Permitted Transfers\" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain \"Permitted Transfers\" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock."}],"balance_after":1000000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001209191-21-010326","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919121010326/doc4.xml","form_type":"4"}},{"id":2863781,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2021-02-12T22:45:12.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":2000000,"price":10,"value":20000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On October 20, 2020, the Issuer entered into subscription agreements (the \"Subscription Agreements\") with certain investors (the \"PIPE Investors\") pursuant to which such investors agreed to purchase, immediately prior to the closing of the Business Combination, as defined herein, an aggregate of $476,550,000 of the Issuer's shares of Class A Common Stock at a price of $10.00 per share, or an aggregate of 47,655,000 shares of Class A Common Stock. The Reporting Person is among the PIPE Investors."}],"balance_after":58645012,"source":{"system":"sec-edgar","filing":"0001209191-21-010326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919121010326/doc4.xml","form_type":"4"}},{"id":2863780,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2021-02-12T22:45:12.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":56645012,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received pursuant to the Agreement and Plan of Merger, dated as of October 20, 2020, by and among Panacea Acquisition Corp. (\"Panacea\") and Panacea Merger Subsidiary Corp., a direct, wholly-owned subsidiary of Panacea (\"Merger Sub\"), and Nuvation Bio Inc. (\"Legacy Nuvation\") pursuant to which, as a result of a merger between Legacy Nuvation and Merger Sub, Legacy Nuvation became a direct, wholly-owned subsidiary of Panacea, which subsequently changed its name to Nuvation Bio Inc. (the \"Issuer\")."}],"balance_after":56645012,"source":{"system":"sec-edgar","filing":"0001209191-21-010326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120919121010326/doc4.xml","form_type":"4"}},{"id":3088600,"issuer":{"id":147975,"kind":"organization","name":"ARYA SCIENCES ACQUISITION CORP.","symbol":"ARYA"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2020-07-07T01:53:14.000Z","date":"2020-07-01","kind":"disposition_to_issuer","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the merger of ARYA Sciences Acquisition Corp. (the \"Issuer\") with and into a subsidiary of Immatics N.V. (\"IMTX\"), and a series of related transactions (collectively, the \"Business Combination\"), the Class B Ordinary Shares, par value $0.0001 per share, of the Issuer held by the Reporting Person were exchanged for Ordinary Shares, nominal value EURO0.01 per share, of IMTX. Upon consummation of the Business Combination the Reporting Person is no longer subject to the reporting requirements of Section 16 with respect to the Issuer's securities."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the merger of ARYA Sciences Acquisition Corp. (the \"Issuer\") with and into a subsidiary of Immatics N.V. (\"IMTX\"), and a series of related transactions (collectively, the \"Business Combination\"), the Class B Ordinary Shares, par value $0.0001 per share, of the Issuer held by the Reporting Person were exchanged for Ordinary Shares, nominal value EURO0.01 per share, of IMTX. Upon consummation of the Business Combination the Reporting Person is no longer subject to the reporting requirements of Section 16 with respect to the Issuer's securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the merger of ARYA Sciences Acquisition Corp. (the \"Issuer\") with and into a subsidiary of Immatics N.V. (\"IMTX\"), and a series of related transactions (collectively, the \"Business Combination\"), the Class B Ordinary Shares, par value $0.0001 per share, of the Issuer held by the Reporting Person were exchanged for Ordinary Shares, nominal value EURO0.01 per share, of IMTX. Upon consummation of the Business Combination the Reporting Person is no longer subject to the reporting requirements of Section 16 with respect to the Issuer's securities."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the merger of ARYA Sciences Acquisition Corp. (the \"Issuer\") with and into a subsidiary of Immatics N.V. (\"IMTX\"), and a series of related transactions (collectively, the \"Business Combination\"), the Class B Ordinary Shares, par value $0.0001 per share, of the Issuer held by the Reporting Person were exchanged for Ordinary Shares, nominal value EURO0.01 per share, of IMTX. Upon consummation of the Business Combination the Reporting Person is no longer subject to the reporting requirements of Section 16 with respect to the Issuer's securities."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-20-018573","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1310880/000089924320018573/doc4.xml","form_type":"4"}},{"id":3111897,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Buy Ordinary Shares","published_at":"2020-06-12T22:07:43.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":5101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 5,101 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2021 annual general meeting of shareholders."}],"balance_after":5101,"derivative":{"exercise_price":67.89,"expiration_date":"2030-06-10","underlying":"Ordinary Shares","underlying_shares":5101},"source":{"system":"sec-edgar","filing":"0001645113-20-000087","document":"wf-form4_159199964610645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000087/wf-form4_159199964610645.xml","form_type":"4"}},{"id":3111896,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-12T22:07:43.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":2541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2021 annual general meeting of shareholders."}],"balance_after":5900,"source":{"system":"sec-edgar","filing":"0001645113-20-000087","document":"wf-form4_159199964610645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511320000087/wf-form4_159199964610645.xml","form_type":"4"}},{"id":3133838,"issuer":{"id":4473,"kind":"organization","name":"ESTABLISHMENT LABS HOLDINGS INC."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-05-27T20:42:54.000Z","date":"2020-05-26","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on the earlier of May 26, 2021 or the day prior to the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":10000,"derivative":{"exercise_price":18.14,"expiration_date":"2030-05-26","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-20-008467","document":"wf-form4_159061215745964.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688757/000162828020008467/wf-form4_159061215745964.xml","form_type":"4"}},{"id":3500715,"issuer":{"id":4473,"kind":"organization","name":"ESTABLISHMENT LABS HOLDINGS INC."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-06-05T20:37:06.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in full on the earlier of June 3, 2020 or the day prior to the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":10000,"derivative":{"exercise_price":23.05,"expiration_date":"2029-06-03","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-19-007590","document":"wf-form4_155976701181511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688757/000162828019007590/wf-form4_155976701181511.xml","form_type":"4"}},{"id":3511823,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Buy Ordinary Shares","published_at":"2019-05-24T20:24:18.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":6340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 6,340 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2020 annual general meeting of shareholders."}],"balance_after":6340,"derivative":{"exercise_price":51.36,"expiration_date":"2029-05-22","underlying":"Ordinary Shares","underlying_shares":6340},"source":{"system":"sec-edgar","filing":"0001209191-19-032714","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119032714/doc4.xml","form_type":"4"}},{"id":3511822,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-24T20:24:18.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":3359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2020 annual general meeting of shareholders."}],"balance_after":3359,"source":{"system":"sec-edgar","filing":"0001209191-19-032714","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919119032714/doc4.xml","form_type":"4"}},{"id":3908484,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Buy Ordinary Shares","published_at":"2018-06-05T01:42:18.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":45137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will vest in equal parts on the earlier of each of the following dates: (i) the first, second and third anniversary of the grant date and (ii) the day immediately preceding of the Company's 2019, 2020 and 2021 annual general meeting of shareholders, respectively."}],"balance_after":45137,"derivative":{"exercise_price":31.45,"expiration_date":"2028-05-31","underlying":"Ordinary Shares","underlying_shares":45137},"source":{"system":"sec-edgar","filing":"0001209191-18-035427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645113/000120919118035427/doc4.xml","form_type":"4"}},{"id":4111224,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-03T13:48:21.000Z","date":"2017-12-29","kind":"exercise","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is immediately exercisable, subject to a repurchase right in favor of the Issuer that lapses as the option vests. 20% of the common shares underlying the option vest on December 29, 2018, and the balance of the shares vest in a series of 16 successive equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date, but only if the 30-consecutive day volume-weighted average closing price of the Issuer's common shares equals or exceeds $7.91 at any point during the 10-year term of the option."}],"balance_after":2000000,"derivative":{"exercise_price":5.27,"expiration_date":"2027-12-29","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001104659-18-000371","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1310880/000110465918000371/a4.xml","form_type":"4"}},{"id":4349551,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Executive Officer"}}],"security":"Common Shares","published_at":"2017-04-19T20:06:28.000Z","date":"2017-04-17","kind":"purchase","acquired":true,"shares":539375,"price":18.54,"value":10000012.5,"ownership":{"direct":true},"balance_after":539375,"source":{"system":"sec-edgar","filing":"0001209191-17-027436","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1310880/000120919117027436/doc4.xml","form_type":"4"}},{"id":4354369,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-11T21:55:37.000Z","date":"2017-04-07","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is immediately exercisable, subject to a repurchase right in favor of the Issuer that lapses as the option vests.  20% of the common shares underlying the option vest on April 7, 2018, and the balance of the shares vest in a series of 16 successive equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date, but only if the 30-consecutive day volume-weighted average closing price of the Issuer's common shares equals or exceeds $100.00 per common share at any point during the 10-year term of the option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In the event that specified results from a clinical trial being conducted by the Issuer are not met by December 31, 2017, then the $100.00 per common share price referred to in footnote (2) will be reduced to $15.00 per common share.  Subject to the achievement of the volume-weighted average closing price condition described herein, vesting is subject to acceleration in specified circumstances, including a change in control of the Issuer or the Reporting Person's termination without cause or resignation for good reason."}],"balance_after":2000000,"derivative":{"exercise_price":15.13,"expiration_date":"2027-04-07","underlying":"Common Shares","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001209191-17-026601","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1310880/000120919117026601/doc4.xml","form_type":"4"}},{"id":4354368,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-11T21:55:37.000Z","date":"2017-04-07","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is immediately exercisable, subject to a repurchase right in favor of the Issuer that lapses as the option vests.  20% of the common shares underlying the option vest on April 7, 2018, and the balance of the common shares vest in a series of 16 successive equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.  Vesting is subject to acceleration in specified circumstances, including a change in control of the Issuer or the Reporting Person's termination without cause or resignation for good reason."}],"balance_after":2000000,"derivative":{"exercise_price":15.13,"expiration_date":"2027-04-07","underlying":"Common Shares","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001209191-17-026601","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1310880/000120919117026601/doc4.xml","form_type":"4"}},{"id":4592131,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Appreciation Rights","published_at":"2016-09-30T17:45:08.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":534400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This stock appreciation right (the \"SAR\") was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share base price of the SAR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This stock appreciation right (the \"SAR\") was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share base price of the SAR."}],"balance_after":0,"derivative":{"exercise_price":12.1975,"expiration_date":"2021-12-09","underlying":"Common Stock","underlying_shares":534400},"source":{"system":"sec-edgar","filing":"0001209191-16-143381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143381/doc4.xml","form_type":"4"}},{"id":4592130,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2016-09-30T17:45:08.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":77337,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The number of shares subject to the performance-based restricted stock unit (the \"PSUs\") is based on deemed satisfaction of all applicable performance goals at the maximum levels."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The PSUs were cancelled in the Merger and, in lieu of any issuance of shares in settlement of such PSUs, converted into the right to receive cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes. In connection with the Merger, vesting of the PSUs was accelerated and the PSUs became fully vested effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The PSUs were cancelled in the Merger and, in lieu of any issuance of shares in settlement of such PSUs, converted into the right to receive cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes. In connection with the Merger, vesting of the PSUs was accelerated and the PSUs became fully vested effective immediately prior to the effective time of the Merger."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The number of shares subject to the performance-based restricted stock unit (the \"PSUs\") is based on deemed satisfaction of all applicable performance goals at the maximum levels."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2020-02-18","underlying":"Common Stock","underlying_shares":77337},"source":{"system":"sec-edgar","filing":"0001209191-16-143381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143381/doc4.xml","form_type":"4"}},{"id":4592129,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-30T17:45:08.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":205500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":35.77,"expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":205500},"source":{"system":"sec-edgar","filing":"0001209191-16-143381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143381/doc4.xml","form_type":"4"}},{"id":4592128,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-30T17:45:08.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":228000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":52.665,"expiration_date":"2025-02-17","underlying":"Common Stock","underlying_shares":228000},"source":{"system":"sec-edgar","filing":"0001209191-16-143381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143381/doc4.xml","form_type":"4"}},{"id":4592127,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-30T17:45:08.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":266000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":41.775,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":266000},"source":{"system":"sec-edgar","filing":"0001209191-16-143381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143381/doc4.xml","form_type":"4"}},{"id":4592126,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-30T17:45:08.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":310000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":27.43,"expiration_date":"2022-12-17","underlying":"Common Stock","underlying_shares":310000},"source":{"system":"sec-edgar","filing":"0001209191-16-143381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143381/doc4.xml","form_type":"4"}},{"id":4592125,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-30T17:45:08.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":3.3675,"expiration_date":"2020-12-15","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-16-143381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143381/doc4.xml","form_type":"4"}},{"id":4592124,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-30T17:45:08.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":593750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":8.64,"expiration_date":"2019-12-15","underlying":"Common Stock","underlying_shares":593750},"source":{"system":"sec-edgar","filing":"0001209191-16-143381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143381/doc4.xml","form_type":"4"}},{"id":4592123,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-30T17:45:08.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":366194,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":4.6925,"expiration_date":"2018-10-31","underlying":"Common Stock","underlying_shares":366194},"source":{"system":"sec-edgar","filing":"0001209191-16-143381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143381/doc4.xml","form_type":"4"}},{"id":4592122,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-30T17:45:08.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":448888,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":5.2925,"expiration_date":"2017-10-01","underlying":"Common Stock","underlying_shares":448888},"source":{"system":"sec-edgar","filing":"0001209191-16-143381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143381/doc4.xml","form_type":"4"}},{"id":4592121,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-09-30T17:45:08.000Z","date":"2016-09-28","kind":"other","acquired":false,"shares":145120,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger (the \"Merger Agreement\"), dated August 20, 2016, among the Issuer, Pfizer Inc., a Delaware corporation (\"Parent\"), and Montreal, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (\"Purchaser\"), in exchange for a cash consideration of $81.50 per share (without interest) subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\").  In connection with the Merger, Purchaser offered to purchase all of the outstanding shares of common stock, par value $0.01 per share of the Issuer, at a price of $81.50 per share, net to the seller in cash (without interest) but subject to any required withholding of taxes, upon the terms and conditions set forth in the offer to purchase dated August 30, 2016, and in the related letter of transmittal."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger (the \"Merger Agreement\"), dated August 20, 2016, among the Issuer, Pfizer Inc., a Delaware corporation (\"Parent\"), and Montreal, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (\"Purchaser\"), in exchange for a cash consideration of $81.50 per share (without interest) subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\").  In connection with the Merger, Purchaser offered to purchase all of the outstanding shares of common stock, par value $0.01 per share of the Issuer, at a price of $81.50 per share, net to the seller in cash (without interest) but subject to any required withholding of taxes, upon the terms and conditions set forth in the offer to purchase dated August 30, 2016, and in the related letter of transmittal."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-16-143381","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143381/doc4.xml","form_type":"4"}},{"id":4592120,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-09-30T17:45:08.000Z","date":"2016-09-28","kind":"disposition_to_issuer","acquired":false,"shares":94290,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger (the \"Merger Agreement\"), dated August 20, 2016, among the Issuer, Pfizer Inc., a Delaware corporation (\"Parent\"), and Montreal, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (\"Purchaser\"), in exchange for a cash consideration of $81.50 per share (without interest) subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\").  In connection with the Merger, Purchaser offered to purchase all of the outstanding shares of common stock, par value $0.01 per share of the Issuer, at a price of $81.50 per share, net to the seller in cash (without interest) but subject to any required withholding of taxes, upon the terms and conditions set forth in the offer to purchase dated August 30, 2016, and in the related letter of transmittal."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents unvested restricted stock units (the \"RSUs\") that were cancelled in the Merger and, in lieu of any issuance of shares in settlement of such RSUs, converted into the right to receive cash payment equal to $81.50 per share (without interest) subject to any required withholding of taxes.  In connection with the Merger, vesting of the RSUs was accelerated and the RSUs became fully vested effective immediately prior to the effective time of the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger (the \"Merger Agreement\"), dated August 20, 2016, among the Issuer, Pfizer Inc., a Delaware corporation (\"Parent\"), and Montreal, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (\"Purchaser\"), in exchange for a cash consideration of $81.50 per share (without interest) subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\").  In connection with the Merger, Purchaser offered to purchase all of the outstanding shares of common stock, par value $0.01 per share of the Issuer, at a price of $81.50 per share, net to the seller in cash (without interest) but subject to any required withholding of taxes, upon the terms and conditions set forth in the offer to purchase dated August 30, 2016, and in the related letter of transmittal."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-16-143381","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143381/doc4.xml","form_type":"4"}},{"id":4592119,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-09-30T17:45:08.000Z","date":"2016-09-28","kind":"other","acquired":false,"shares":1470087,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger (the \"Merger Agreement\"), dated August 20, 2016, among the Issuer, Pfizer Inc., a Delaware corporation (\"Parent\"), and Montreal, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (\"Purchaser\"), in exchange for a cash consideration of $81.50 per share (without interest) subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\").  In connection with the Merger, Purchaser offered to purchase all of the outstanding shares of common stock, par value $0.01 per share of the Issuer, at a price of $81.50 per share, net to the seller in cash (without interest) but subject to any required withholding of taxes, upon the terms and conditions set forth in the offer to purchase dated August 30, 2016, and in the related letter of transmittal."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger (the \"Merger Agreement\"), dated August 20, 2016, among the Issuer, Pfizer Inc., a Delaware corporation (\"Parent\"), and Montreal, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (\"Purchaser\"), in exchange for a cash consideration of $81.50 per share (without interest) subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\").  In connection with the Merger, Purchaser offered to purchase all of the outstanding shares of common stock, par value $0.01 per share of the Issuer, at a price of $81.50 per share, net to the seller in cash (without interest) but subject to any required withholding of taxes, upon the terms and conditions set forth in the offer to purchase dated August 30, 2016, and in the related letter of transmittal."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-16-143381","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116143381/doc4.xml","form_type":"4"}},{"id":4600533,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-19T16:49:07.000Z","date":"2016-09-15","kind":"exercise","acquired":false,"shares":21308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":366194,"derivative":{"exercise_price":4.6925,"expiration_date":"2018-10-31","underlying":"Common Stock","underlying_shares":21308},"source":{"system":"sec-edgar","filing":"0001209191-16-141999","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116141999/doc4.xml","form_type":"4"}},{"id":4600532,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-19T16:49:07.000Z","date":"2016-09-15","kind":"exercise","acquired":false,"shares":9446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":448888,"derivative":{"exercise_price":5.2925,"expiration_date":"2017-10-01","underlying":"Common Stock","underlying_shares":9446},"source":{"system":"sec-edgar","filing":"0001209191-16-141999","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116141999/doc4.xml","form_type":"4"}},{"id":4600531,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-09-19T16:49:07.000Z","date":"2016-09-15","kind":"exercise","acquired":true,"shares":21308,"price":4.6925,"value":99987.79,"ownership":{"direct":true},"balance_after":1564377,"source":{"system":"sec-edgar","filing":"0001209191-16-141999","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116141999/doc4.xml","form_type":"4"}},{"id":4600530,"issuer":{"id":181987,"kind":"organization","name":"MEDIVATION, INC.","symbol":"MDVN"},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-09-19T16:49:07.000Z","date":"2016-09-15","kind":"exercise","acquired":true,"shares":9446,"price":5.2925,"value":49992.955,"ownership":{"direct":true},"balance_after":1543069,"source":{"system":"sec-edgar","filing":"0001209191-16-141999","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1011835/000120919116141999/doc4.xml","form_type":"4"}}]}